MARIGLEN GJONI: Open Payments
NPI 1871121160 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 39 payments from 8 companies in 2025. Trend: 2023 $615 · 2024 $550 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $217 |
| GlaxoSmithKline, LLC. | 11 | $201 |
| Lilly USA, LLC | 11 | $147 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Medtronic, Inc. | 1 | $27 |
| Optinose US, Inc. | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
Products named: DUPIXENT, NUCALA, ZEPBOUND, XOLAIR, PROPEL, Xhance, MOUNJARO, JOURNAVX.
Industry payments across WI — which companies pay providers there.
